NextGen Jane

NextGen Jane, Inc.NextGen Jane, Inc. was founded in 2014 and operates from Oakland, US. It specializes in women's reproductive health through the collection and analysis of menstrual fluid. The company has completed a total of 3 deals, with its most recent deal occurring on September 20, 2023.10 mn.NextGen Jane specializes in innovative health solutions focused on women's reproductive health, primarily through the collection and analysis of menstrual fluid samples. Their core offering is a patented collection kit designed for home use, which includes organic cotton tampons specifically for gathering samples. This allows users to safely send their samples to the company for genomic analysis, enabling the connection between menstrual cycle data and broader health outcomes, including reproductive issues such as endometriosis.S. market, although potential expansion into other regions may be considered in the future.NextGen Jane generates revenue through a subscription-based model targeting consumers who participate in their longitudinal study of menstrual health. Clients typically enroll in the program by signing up for a subscription that includes the collection kit and access to ongoing insights derived from their genomic data. Transactions are structured around these subscriptions, allowing customers to engage continuously with the company and receive regular updates about their health insights. The pricing structure is designed to facilitate accessibility for individuals seeking to gain a deeper understanding of their reproductive health.In September 2023, NextGen Jane, Inc. Specific targeted regions for expansion remain under consideration, with potential plans to launch new products by late 2024. This strategy aligns with their mission to broaden access to reproductive health insights.

1. Series A

   Mar 19, 2019

   Amount

   $8.8M

   Investors

   Locked